PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.
Saved in:
| Title: | PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer. |
|---|---|
| Authors: | Dosset M; INSERM, U1231, Dijon, France.; INSERM, U1098, Besançon, France.; LabEx LipSTIC, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France., Vargas TR; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Lagrange A; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Boidot R; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France., Végran F; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France., Roussey A; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Chalmin F; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Dondaine L; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Paul C; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Lauret Marie-Joseph E; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France., Martin F; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Ryffel B; University of Cape Town, RSA, CNRS, UMR7355, Orleans, France, IDM., Borg C; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Department of Medical Oncology, University Hospital of Besançon, France., Adotévi O; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Department of Medical Oncology, University Hospital of Besançon, France., Ghiringhelli F; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France., Apetoh L; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France. |
| Source: | Oncoimmunology [Oncoimmunology] 2018 Mar 15; Vol. 7 (6), pp. e1433981. Date of Electronic Publication: 2018 Mar 15 (Print Publication: 2018). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29872568 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dosset+M%22">Dosset M</searchLink>; INSERM, U1231, Dijon, France.; INSERM, U1098, Besançon, France.; LabEx LipSTIC, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Vargas+TR%22">Vargas TR</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Lagrange+A%22">Lagrange A</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Boidot+R%22">Boidot R</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Végran+F%22">Végran F</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Roussey+A%22">Roussey A</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Chalmin+F%22">Chalmin F</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Dondaine+L%22">Dondaine L</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Paul+C%22">Paul C</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Lauret+Marie-Joseph+E%22">Lauret Marie-Joseph E</searchLink>; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Martin+F%22">Martin F</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Ryffel+B%22">Ryffel B</searchLink>; University of Cape Town, RSA, CNRS, UMR7355, Orleans, France, IDM.<br /><searchLink fieldCode="AU" term="%22Borg+C%22">Borg C</searchLink>; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Department of Medical Oncology, University Hospital of Besançon, France.<br /><searchLink fieldCode="AU" term="%22Adotévi+O%22">Adotévi O</searchLink>; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Department of Medical Oncology, University Hospital of Besançon, France.<br /><searchLink fieldCode="AU" term="%22Ghiringhelli+F%22">Ghiringhelli F</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Apetoh+L%22">Apetoh L</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2018 Mar 15; Vol. 7 (6), pp. e1433981. <i>Date of Electronic Publication: </i>2018 Mar 15 (<i>Print Publication: </i>2018). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29872568 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/2162402X.2018.1433981 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1433981 Titles: – TitleFull: PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dosset M – PersonEntity: Name: NameFull: Vargas TR – PersonEntity: Name: NameFull: Lagrange A – PersonEntity: Name: NameFull: Boidot R – PersonEntity: Name: NameFull: Végran F – PersonEntity: Name: NameFull: Roussey A – PersonEntity: Name: NameFull: Chalmin F – PersonEntity: Name: NameFull: Dondaine L – PersonEntity: Name: NameFull: Paul C – PersonEntity: Name: NameFull: Lauret Marie-Joseph E – PersonEntity: Name: NameFull: Martin F – PersonEntity: Name: NameFull: Ryffel B – PersonEntity: Name: NameFull: Borg C – PersonEntity: Name: NameFull: Adotévi O – PersonEntity: Name: NameFull: Ghiringhelli F – PersonEntity: Name: NameFull: Apetoh L IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 03 Text: 2018 Mar 15 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 2162-4011 Numbering: – Type: volume Value: 7 – Type: issue Value: 6 Titles: – TitleFull: Oncoimmunology Type: main |
| ResultId | 1 |